Company performance
Add to research
Current Price
as of Apr 21, 2025$4.99
P/E Ratio
N/A
Market Cap
$261.17M
Description
Add to research
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Metrics
Add to research
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerTSVT
- Price$4.99+0.20%
Trading Information
- Market cap$261.17M
- Float90.67%
- Average Daily Volume (1m)1,161,074
- Average Daily Volume (3m)1,266,967
- EPS-$1.10
Company
- Revenue$37.86M
- Rev growth (1yr)-62.28%
- Net income-$57.25M
- Gross margin21.67%
- EBITDA margin-260.01%
- EBITDA-$98.45M
- EV$222.48M
- EV/Revenue5.88
- P/EN/A
- P/S6.88
- P/B1.22
- Debt/Equity115.61
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account